Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic Malignancies.

Saved in:
Bibliographic Details
Title: Dermatologic Adverse Events Following CD19-Directed CAR T-Cell Therapy in Hematologic Malignancies.
Authors: Storgard R; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Reingold RE; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Parisi R; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Dusza SW; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Noor SJ; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Dermatology, Weill Cornell Medical College, New York, NY., Park JH; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sauter CS; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Curran KJ; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics, Weill Cornell Medical College, New York, NY., Palomba ML; Department of Medicine, Weill Cornell Medical College, New York, NY; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Shah G; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Shouval R; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Perales MA; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Scordo M; Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Dermatology, Weill Cornell Medical College, New York, NY. Electronic address: markovaa@mskcc.org.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Jan; Vol. 26 (1), pp. e120-e126. Date of Electronic Publication: 2025 Sep 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2025.09.012